Kobusine derivative-2
Kobusine derivative-2, a kobusine derivative, has antiproliferative activity against cancer cells. Kobusine derivative-2 can induce the arrest of MDA-MB-231 cells in the sub-G1 phase. Anticancer activity[1].
Product Specifications
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kobusine-derivative-2.html
Solubility
10 mM in DMSO
Smiles
C[C@]12[C@]3([H])[C@]4(CCC1)[C@@](N(C2)[C@H]3C5)([H])[C@@H](C[C@@H]6C7=C)[C@@]5([C@@H]7OC(C8=CC=C(C(Cl)Cl)C=C8)=O)[C@@]4([H])[C@H]6OC(C9=CC=C(C(Cl)Cl)C=C9)=O
Molecular Formula
C36H35Cl4NO4
Molecular Weight
687.48
References & Citations
[1]Koji Wada, et al. Discovery of C20-Diterpenoid Alkaloid Kobusine Derivatives Exhibiting Sub-G1 Inducing Activity. American Chemical Society. 2022
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2290-500 1x 500 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/2290R), 0.2mg/mL
Sign In for Pricing
View Details 
![PE Anti-Mouse CD90 Antibody[M5/49.4.1]](https://cdn.genprice.uk/products/763/68dd14ac061270361e7d2f49/imageurl/e-ab-f1283d.webp)